These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33414055)

  • 1. Mutation Profile of Thymic Carcinoma and Thymic Neuroendocrine Tumor by Targeted Next-generation Sequencing.
    Sakane T; Sakamoto Y; Masaki A; Murase T; Okuda K; Nakanishi R; Inagaki H
    Clin Lung Cancer; 2021 Mar; 22(2):92-99.e4. PubMed ID: 33414055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic profiling of thymic carcinoma using targeted next-generation sequencing.
    Shitara M; Okuda K; Suzuki A; Tatematsu T; Hikosaka Y; Moriyama S; Sasaki H; Fujii Y; Yano M
    Lung Cancer; 2014 Nov; 86(2):174-9. PubMed ID: 25249426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3.
    Sakane T; Murase T; Okuda K; Saida K; Masaki A; Yamada T; Saito Y; Nakanishi R; Inagaki H
    Histopathology; 2019 Nov; 75(5):755-766. PubMed ID: 31179560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of gene mutations in KIT-positive thymic epithelial tumors.
    Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
    Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
    Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
    Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massively parallel sequencing identifies recurrent mutations in TP53 in thymic carcinoma associated with poor prognosis.
    Moreira AL; Won HH; McMillan R; Huang J; Riely GJ; Ladanyi M; Berger MF
    J Thorac Oncol; 2015 Feb; 10(2):373-80. PubMed ID: 25299233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
    Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
    Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of clinicopathologic features on survival of patients with thymic carcinomas and thymic neuroendocrine tumors: A population-based analysis.
    Song Q; Zhang LL; Qi Y; Xing KL; Wu XH
    Curr Probl Cancer; 2019 Oct; 43(5):411-420. PubMed ID: 30952367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.
    Thomas A; Rajan A; Berman A; Tomita Y; Brzezniak C; Lee MJ; Lee S; Ling A; Spittler AJ; Carter CA; Guha U; Wang Y; Szabo E; Meltzer P; Steinberg SM; Trepel JB; Loehrer PJ; Giaccone G
    Lancet Oncol; 2015 Feb; 16(2):177-86. PubMed ID: 25592632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and mutational status of c-kit in thymic epithelial tumors.
    Petrini I; Zucali PA; Lee HS; Pineda MA; Meltzer PS; Walter-Rodriguez B; Roncalli M; Santoro A; Wang Y; Giaccone G
    J Thorac Oncol; 2010 Sep; 5(9):1447-53. PubMed ID: 20651610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of tumour size in completely resected thymic epithelial tumours.
    Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
    Eur J Cardiothorac Surg; 2016 Dec; 50(6):1068-1074. PubMed ID: 27999073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
    Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
    Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Survival After Surgical Treatment of Thymic Carcinoma: A Retrospective Analysis from the Chinese Alliance for Research of Thymoma Database.
    Fu H; Gu ZT; Fang WT; Fu JH; Shen Y; Han YT; Yu ZT; Li Y; Tan LJ; Pang LW; Chen KN
    Ann Surg Oncol; 2016 Feb; 23(2):619-25. PubMed ID: 26474558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and mutation statuses of epidermal growth factor receptor in thymic epithelial tumors.
    Suzuki E; Sasaki H; Kawano O; Endo K; Haneda H; Yukiue H; Kobayashi Y; Yano M; Fujii Y
    Jpn J Clin Oncol; 2006 Jun; 36(6):351-6. PubMed ID: 16762968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
    Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-related gene expression levels in thymic carcinoma and Type B3 thymoma.
    Karube Y; Kobayashi S; Maeda S; Sado T; Ishihama H; Chida M
    J Cardiothorac Surg; 2016 May; 11(1):85. PubMed ID: 27387303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Recurrent TERT Promoter Mutations in Intrathyroid Thymic Carcinomas.
    Tahara I; Oishi N; Mochizuki K; Oyama T; Miyata K; Miyauchi A; Hirokawa M; Katoh R; Kondo T
    Endocr Pathol; 2020 Sep; 31(3):274-282. PubMed ID: 32594366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis.
    Zeng H; Yang W; Xu B; Zou J; Su C; Zhong B; Zhu H; Chen Z
    BMC Cancer; 2020 Sep; 20(1):928. PubMed ID: 32993581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of p16
    Aesif SW; Aubry MC; Yi ES; Kloft-Nelson SM; Jenkins SM; Spears GM; Greipp PT; Sukov WR; Roden AC
    J Thorac Oncol; 2017 May; 12(5):860-871. PubMed ID: 28179162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.